Emmaus Life Sciences (EMMA) Asset Utilization Ratio (2011 - 2026)
Emmaus Life Sciences' Asset Utilization Ratio came in at 0.89 for Q2 2026, up 45.0% from 0.61 a year earlier and up 47.8% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
For FY2025, Emmaus Life Sciences' Asset Utilization Ratio was 0.55, down 2.4% from FY2024.
- Going back by year, Asset Utilization Ratio was 0.57 in FY2024 (-20.2%), 0.71 in FY2023 (+102.5%), 0.35 in FY2022 (-1.2%) and 0.35 in FY2021 (-9.0%).
- The Q2 2026 figure represents the highest quarterly Asset Utilization Ratio since Q3 2012.
- Year-over-year, Asset Utilization Ratio increased in two of the last eight quarters, with an average decline of 1.4%.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q4 2023 (growth of 76.1%), and the weakest in Q3 2025 (a decline of 29.7%).
- Business Quant data shows EMMA's Asset Utilization Ratio at 0.60 (Q1 2026), 0.59 (Q4 2025) and 0.54 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 0.31 |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn | 0.89 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.89 |
| Mar 31, 2026 | 0.60 |
| Dec 31, 2025 | 0.59 |
| Sep 30, 2025 | 0.54 |
| Jun 30, 2025 | 0.61 |
| Mar 31, 2025 | 0.72 |
| Dec 31, 2024 | 0.65 |
| Sep 30, 2024 | 0.77 |
| Jun 30, 2024 | 0.72 |
| Mar 31, 2024 | 0.78 |
| Dec 31, 2023 | 0.72 |
| Sep 30, 2023 | 0.58 |
| Jun 30, 2023 | 0.57 |
| Mar 31, 2023 | 0.45 |
| Dec 31, 2022 | 0.41 |
| Sep 30, 2022 | 0.35 |
| Jun 30, 2022 | 0.33 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.35 |
| Sep 30, 2021 | 0.39 |
API Access
Emmaus Life Sciences Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();